Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses
17 août 2026 mis à jour par: Ang Wei How Darryl, National University of Singapore
Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses: A Mixed Methods Study
The goal of this clinical trial is to evaluate whether the PEACE program can improve early career registered nurses' registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death, and self-efficacy in initiating advanced care planning conversations
This study aims to address the following research questions:
- Does the PEACE program improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations?
- What are the participants' experiences of participating in the PEACE program?
Researchers will compare participants who receive the PEACE program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.
Participants will:
- Complete online questionnaires measuring attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.
- Participate in a facilitator-led group discussion session about experiences of patients' deaths, coping with patients' death and dying, communications with patients and/or family members about death and dying, and discussing advance care planning with patients and/or family members (intervention group only).
- Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
- Complete follow-up surveys, including a 3-month follow-up assessing whether participants have engage with any patients and/or their family members in advance care planning conversations.
Aperçu de l'étude
Statut
Pas encore de recrutement
Les conditions
Type d'étude
Interventionnel
Inscription (Estimé)
150
Phase
- N'est pas applicable
Contacts et emplacements
Cette section fournit les coordonnées de ceux qui mènent l'étude et des informations sur le lieu où cette étude est menée.
Coordonnées de l'étude
- Nom: Darryl Ang, PhD
- Numéro de téléphone: +65 65167792
- E-mail: darrylang@nus.edu.sg
Lieux d'étude
-
-
-
Singapore, Singapour
- National University of Singapore
-
Contact:
- Darryl Ang, PhD
- Numéro de téléphone: +65 65167792
- E-mail: darrylang@nus.edu.sg
-
-
Critères de participation
Les chercheurs recherchent des personnes qui correspondent à une certaine description, appelée critères d'éligibilité. Certains exemples de ces critères sont l'état de santé général d'une personne ou des traitements antérieurs.
Critère d'éligibilité
Âges éligibles pour étudier
- Adulte
- Adulte plus âgé
Accepte les volontaires sains
Oui
La description
Inclusion Criteria:
- Registered nurses within the first five years of practice
- Between the ages of 21 to 65 years
- Currently working in a healthcare setting in SIngapore
Exclusion Criteria:
- Participated in a similar death conversation program
- Received training in Advance Care Planning or Serious Illness Conversations
- Any self-reported history of mental health disorders (e.g., depression), or neurological disorders (e.g., brain tumors)
Plan d'étude
Cette section fournit des détails sur le plan d'étude, y compris la façon dont l'étude est conçue et ce que l'étude mesure.
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: La prévention
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Aucun (étiquette ouverte)
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Expérimental: Intervention Group - on site group discussions + online learning session
Participants in this arm will receive the two-session PEACE Program. Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering:
Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums. |
Une session d'apprentissage asynchrone en ligne avec de courtes vidéos sur les ACP (Advance Care Planning) et des forums de discussion.
On site, facilitator-led group discussion lasting 2 hours, covering: 1) Experiences of patients' deaths; 2) Coping with patients' death and dying; 3) Communication with patients and/or family members about death and dying; 4) Discussing advance care planning with patients and/or family members
|
|
Comparateur actif: Control Group - Only online learning session
Participants in this arm will only receive the online ACP education component, identical to Session 2 of the PEACE programme.
No facilitator-led group discussions are provided.
|
Une session d'apprentissage asynchrone en ligne avec de courtes vidéos sur les ACP (Advance Care Planning) et des forums de discussion.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Frommelt Attitude Toward Care of the Dying Scale
Délai: Baseline
|
A 30-item 5 point Likert scale.
Positive items are scored one (strongly disagree) to five (strongly agree).
Scores are reversed for negative items.
Possible scores can range from 30-150.
A higher score indicates a more positive attitude toward caring for this patient population.
|
Baseline
|
|
Frommelt Attitude Toward Care of the Dying Scale
Délai: Post-test (Immediately at end of 2-weeks intervention)
|
A 30-item 5 point Likert scale.
Positive items are scored one (strongly disagree) to five (strongly agree).
Scores are reversed for negative items.
Possible scores can range from 30-150.
A higher score indicates a more positive attitude toward caring for this patient population.
|
Post-test (Immediately at end of 2-weeks intervention)
|
|
Frommelt Attitude Toward Care of the Dying Scale
Délai: 3 months follow-up
|
A 30-item 5 point Likert scale.
Positive items are scored one (strongly disagree) to five (strongly agree).
Scores are reversed for negative items.
Possible scores can range from 30-150.
A higher score indicates a more positive attitude toward caring for this patient population.
|
3 months follow-up
|
Mesures de résultats secondaires
Mesure des résultats |
Description de la mesure |
Délai |
|---|---|---|
|
Palliative care self-efficacy scale
Délai: Baseline
|
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently).
Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
|
Baseline
|
|
Palliative care self-efficacy scale
Délai: Post-test (Immediately at end of 2-weeks intervention)
|
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently).
Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
|
Post-test (Immediately at end of 2-weeks intervention)
|
|
Palliative care self-efficacy scale
Délai: 3 months follow-up
|
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently).
Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
|
3 months follow-up
|
|
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Délai: Baseline
|
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
|
Baseline
|
|
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Délai: Post-test (Immediately at end of 2-weeks intervention)
|
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
|
Post-test (Immediately at end of 2-weeks intervention)
|
|
Advance Care Planning Self-Efficacy (ACP-SE) Scale
Délai: 3 months follow-up
|
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
|
3 months follow-up
|
|
End-of-life planning conversations
Délai: 3 months follow-up
|
Self-reported number of conversations held with patients regarding Advance Care Planning
|
3 months follow-up
|
Collaborateurs et enquêteurs
C'est ici que vous trouverez les personnes et les organisations impliquées dans cette étude.
Parrainer
Dates d'enregistrement des études
Ces dates suivent la progression des dossiers d'étude et des soumissions de résultats sommaires à ClinicalTrials.gov. Les dossiers d'étude et les résultats rapportés sont examinés par la Bibliothèque nationale de médecine (NLM) pour s'assurer qu'ils répondent à des normes de contrôle de qualité spécifiques avant d'être publiés sur le site Web public.
Dates principales de l'étude
Début de l'étude (Estimé)
1 septembre 2026
Achèvement primaire (Estimé)
31 décembre 2027
Achèvement de l'étude (Estimé)
31 décembre 2027
Dates d'inscription aux études
Première soumission
11 août 2026
Première soumission répondant aux critères de contrôle qualité
17 août 2026
Première publication (Réel)
19 août 2026
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
19 août 2026
Dernière mise à jour soumise répondant aux critères de contrôle qualité
17 août 2026
Dernière vérification
1 août 2026
Plus d'information
Termes liés à cette étude
Mots clés
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- NUS-DERC-001647
- A-0010425-00-00 (Autre subvention/numéro de financement: National University of Singapore)
Informations sur les médicaments et les dispositifs, documents d'étude
Étudie un produit pharmaceutique réglementé par la FDA américaine
Non
Étudie un produit d'appareil réglementé par la FDA américaine
Non
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .